NexturnBioscience Co. Ltd (089140) — Capital Reinvestment Ratio
Latest as of September 2025:
0.06x
NexturnBioscience Co. Ltd (089140) has a Capital Reinvestment Ratio of 0.06x as of September 2025, meaning it reinvests 0% of its operating cash flow (₩4.51 Billion) in capital expenditures (₩286.65 Million). See how much free cash does NexturnBioscience Co. Ltd generate to measure how efficiently the company converts operating cash flow to free cash.
Capital Reinvestment Ratio
0.06x
Capex / Operating Cash Flow
Operating Cash Flow
₩4.51 Billion
KRW
Capital Expenditures
₩286.65 Million
KRW
Data as of
Sep 2025
Most recent filing
NexturnBioscience Co. Ltd Capital Reinvestment Ratio (2007–2021)
This chart tracks NexturnBioscience Co. Ltd's Capital Reinvestment Ratio across 12 annual periods.
Annual Capital Reinvestment Ratio for NexturnBioscience Co. Ltd (2007–2021)
Year-by-year Capital Reinvestment Ratio for NexturnBioscience Co. Ltd from 2007 to 2021. For live market cap and broader valuation context, see market cap of NexturnBioscience Co. Ltd.
| Year | Reinvestment Ratio | Operating CF (KRW) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2021 | 0.13x | ₩3.66 Billion | ₩467.60 Million | ▼ -97.5% |
| 2020 | 5.15x | ₩235.94 Million | ₩1.21 Billion | ▼ -23.4% |
| 2019 | 6.72x | ₩2.74 Billion | ₩18.38 Billion | ▲ +32348.4% |
| 2018 | 0.02x | ₩9.63 Billion | ₩199.42 Million | ▼ -87.9% |
| 2017 | 0.17x | ₩5.08 Billion | ₩870.45 Million | ▲ +242.6% |
| 2016 | 0.05x | ₩17.88 Billion | ₩893.46 Million | ▼ -89.4% |
| 2015 | 0.47x | ₩1.92 Billion | ₩906.54 Million | ▲ +34050.2% |
| 2014 | 0.00x | ₩6.48 Billion | ₩8.97 Million | ▼ -100.0% |
| 2010 | 5.15x | ₩235.94 Million | ₩1.21 Billion | ▲ +7445.3% |
| 2009 | 0.07x | ₩998.03 Million | ₩68.11 Million | ▼ -67.3% |
| 2008 | 0.21x | ₩945.34 Million | ₩197.16 Million | ▼ -88.1% |
| 2007 | 1.75x | ₩2.26 Billion | ₩3.97 Billion | — |
Capital Reinvestment Ratio = ABS(Capital Expenditures) / Operating Cash Flow